Previous Close | 0.0294 |
Open | 0.0419 |
Bid | 0.0294 x 0 |
Ask | 0.0302 x 0 |
Day's Range | 0.0294 - 0.0419 |
52 Week Range | 0.0294 - 2.7300 |
Volume | |
Avg. Volume | 2,242 |
Market Cap | 3.472M |
Beta (5Y Monthly) | 0.50 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Gritstone Oncology ( (GRTS) ) has shared an update. Gritstone bio, Inc., a biotech firm specializing in potent vaccines, has voluntarily filed for Chapter 11 bankruptcy to restructure and preserve its value while continuing operations. This move is part of a strategic process to explore alternatives and secure a stalking horse bidder to maximize value, demonstrating commitment to advancing clinical programs. Despite the filing, the company aims to maintain normal operations and minimize impact o
Gritstone bio ( NASDAQ:GRTS ) Second Quarter 2024 Results Key Financial Results Revenue: US$921.0k (down 53% from 2Q...